Source: PR Newswire

Press Release: Evolugate : Evolugate Improves DNA-plasmid Production, Ready to Impact Covid-19 Vaccines Manufacturing Throughput

GAINESVILLE, Fla., March 11, 2021 /PRNewswire/ -- Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing. Plasmids are essential for nucleic acid-based vaccines and gene...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more